Kyle Davis/ Indiana Hemophilia & Thrombosis Center
Sep 25, 2025, 11:18
Kyle Davis – A Valued Member of The LEE Research Advisory Council
National Bleeding Disorders Foundation (NBDF) shared on LinkedIn:
”Dr. Kyle Davis is a board-certified Pediatric Hematologist-Oncologist at the Indiana Hemophilia and Thrombosis Center (IHTC) and a valued member of the LEE Research Advisory Council.
He brings medical expertise, compassionate care, and a deep commitment to advancing research that makes a real difference for the bleeding disorders community.
Learn more about Dr. Kyle here.”
Stay updated with Hemostasis Today.
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities
-
Feb 22, 2026, 09:12Arun V JÖ‰ The Hidden Risks in Every Blood Bag
-
Feb 22, 2026, 08:56Parandzem KhachatryanÖ‰ How Hard Is It to Be a Mom, a Wife, a Professor, and a Doctor All at Once?
-
Feb 22, 2026, 08:46Anirban Sen Gupta Presents Bioinspired Platelet Surrogates at MTEC
-
Feb 22, 2026, 08:31Heghine Khachatryan: Advancing Care for Women and Girls with Bleeding Disorders is A Matter of Equity